СЕРДЕЧНАЯ РЕСИНХРОНИЗИРУЮЩАЯ ТЕРАПИЯ В ЛЕЧЕНИИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
Аннотация
Об авторах
А. Ш. РевишвилиРоссия
Н. М. Неминущий
Россия
Список литературы
1. Heart Rhythm Society 2006; www.hrsonline.org
2. Thom T., Haase N., Rosamond W. et al. Heart Disease and Stroke Statistics-2006 Update. A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006: e85-e151.
3. Агеев Ф.Т., Даниелян М.О., Мареев В.Ю. и соавт. Больные с хронической сердечной недостаточностью в российской амбулаторной практике: особенности контингента, диагностики и лечения: исследование ЭПОХА-ОХСН. Сердечная Недостаточность 2004. - т.5, № 1: 4-7.
4. Фомин И.В., Беленков Ю.Н., Мареев В.Ю. и соавт. Распространенность хронической сердечной недостаточности в Европейской части Российской Федерации -данные ЭПОХА-ХСН. Сердечная Недостаточность 2006. - т.7, № 3: 112-115.
5. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. TRACE Study Group. N. Engl. J. Med. 1995; 333: 1670- 1676.
6. Dargie H. for The CAPRICORN Investigator, Effect of Carvedilol on Outcome After Myocardial Infarction in Patients with Left-Ventricular Dysfunction: The CAPRICORN Randomised Trial. Lancet, 2001; 357: 1385-1390.
7. Julian D.G., Camm A.J., Frangin G., et al. The European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet., 1997; 349: 667-674.
8. Moss A.J., Hall W.J., Cannom D.S. et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia // N. Engl. J. Med. - 1996. - N. 335. - P. 1933-1940.
9. Buxton A.E., Lee K.L., Fisher J.D. et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N. Engl. J. Med., 1999; 341: 1882-90.
10. Buxton A.E., Lee K.L., DiCarlo L., et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N. Engl. J. Med., 2000; 342: 1937-45.
11. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction // N. Eng. J. Med. - 2002. - N. 346. - P. 877-883.
12. NHLBI. Morbidity and Mortality: 2000 Chartbook on Cardiovascular, Lung, and Blood Diseases. Geneva: World Health Organization; 1996.
13. Cleland J.G., Swedberg K., Follath F. et al. The Euro-Heart Failure survey programme a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003; 24 (5): 442-463.
14. Health Care Financing Review, 2003 Medicare and Medicaid Statistical Supplement. (www.cms.hhs.gov/review/supp/2003)
15. Wiggers C.J. The muscular reactions of the mammalian ventricles to artificial surface stimuli. Am J Physiol 1925; 73: 346-78.
16. Grines C.L., Bashore T.M., Boudoulas H. et al., Functional Abnormalities in Isolated Left Bundle Branch Block; The Effect of Interventricular Asynchrony, Circulation 1989; 79: 845-853.
17. Xiao H.B., Lee C.H., Gibson D.G. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br. Heart. J.1991; 66: 443-7.
18. Gerber T.C., Nishimura R.A., Hayes D.L. et al., Left ventricular and biventricular pacing in Congestive Heart Failure, Mayo Clin Proc 2001; 76: 803-812.
19. Verbeek X.A.A.M., Vernooy K., Peschar M. et al., Quantification of interventricular asynchrony during LBBB and ventricular pacing, Am. J. Physiol. Heart. Circ. Physiol. 2002; 283: H1370-H1378.
20. Masoudi F.A., Havranek E.P., Smith G. et al. Gender, age, and heart failure with preserved left ventricular systolic function. J. Am. Coll. Cardiol. 2003; 41: 217-23.
21. Havranek E.P., Masoudi F.A., Westfall K.A. et al. Spectrum of heart failure in older patients: Results from the National Heart Failure Project. Am. Heart J. 2002; 143: 412-417.
22. Shenkman H.J., McKinnon J.E., Khandelwal A.K. et al. Determinants of QRS Prolongation in a Generalized Heart Failure Population: Findings from the Conquest Study [Abstract 2993]. Circulation 2000; 102 (18 Suppl II).
23. Schoeller R., Andresen D., Buttner P. et al. First-or second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 1993; 71: 720-726.
24. Aaronson K., Schwartz J.S., Chen T. et al. Development and prospective validation of a clinical index to prediet survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997; 95: 2660-2667.
25. Farwell D., Patel N.R., Hall A. et al. How many people with heart failure are appropriate for biventricular resynchronization? Eur. Heart. J. 2000; 21: 1246-1250.
26. Pitzalis M.V., Iacoviello M., Romito R. et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J.Am.Coll.Cardiol; 2002; 40: 1615-22.
27. Schuster P., Faerestrand S. Techniques for Identification of Left Ventricular Asynchrony for Cardiac Resynchronization Therapy in Heart Failure. Indian Pacing and Electrophysiology Journal 2005; 5(3): 175-185.
28. Reuter S., Garrigue S., Bordachar P. et al. Intermediate-term results of biventricular pacing in heart failure: Correlation between clinical and hemodynamic data // PACE. - 2000. Vol. 23. - P. 1713-1717.
29. Bordachar P., Garrigue S., Reuter S. et al. Hemodynamic assessment of right, left, and biventricular pacing by peak endocardial acceleration and echocardiography in patients with end-stage heart failure // PACE. - 2000. - Vol. 23. - P. 1726-1730.
30. Cazeau S., Ritter P., Bakdach S., Lazarus A., Limousin M., Henao L., Mundler O., Daubert J.C., Mugica J. Four chamber pacing In dilated cardiomyopathy // Pacing Clin. Electrophysiol. - 1994. - Vol. 17. - P. 1974-1979.
31. Daubert J.C., Ritter P., Le Breton H., et al. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. // PACE. - 1998. Vol. 21. P. 239-245.
32. Blanc J.J., Etienne Y., Gillard M., Mansourati J. et al. Evaluation of different ventricular pacing sites in patients with severe heart failure // Circulation. - 1997. - Vol. 96. - P. 3273-3277.
33. Auriccio A., Salo R. Acute hemodynamic improvement by pacing in patients with severe congestive heart failure // PACE. - 1997. - Vol. 20. - P. 313-324.
34. Kass D.A., Chen C.H., Curry C., Talbot M., Berger R., Fetics B., Nevo E. // Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay // Circulation. - 1999. - Vol. 99. - P. 1567-1573.
35. Leclercq C., Cazeau S., Le Breton H. et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure // J. Am. Coll. Cardiol. - 1998. - Vol. 32. - P. 1825-1831.
36. Kim W.Y., Sogaard P., Mortensen P.T. et al. Three dimensional echocardiography documents haemodynamic improvement by biventricular pacing in patients with severe heart failure // Heart. - 2001. Vol. 85. P. 514-520.
37. Jais P., Shah D.C., Takahashi A. et al. Endocardial biventricular pacing // Eur. Heart. J. - 2000. - Vol. 21. - P. 192A.
38. Reuter S., Garrigue S., Bordachar P. et al. Intermediate-term results of biventricular pacing in heart failure: Correlation between clinical and hemodynamic data // PACE. - 2000. Vol. 23. - P. 1713-1717.
39. Yu C.M., Chau E., Sanderson J.E. et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 2002; V. 105. Р. 438-445.
40. Gras D., Mabo P., Tang T. et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study PACE.1998; Vol. 21. P. 2249-2255.
41. Cazeau S., Leclercq C., Lavergne T. et al. Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med. 2001; Vol. 344. P. 873-880.
42. Haywood G. Biventricular pacing in heart failure: update on results from clinical trials. Curr. Control. Trials Cardiovasc. Med. 2001; Vol. 2. - P. 292-297.
43. Abraham W.T., Fisher W.G., Smith A.L. et al. for the MIRACLE Study Group. Cardiac Resynchronization in Chronic Heart Failure. N. Engl. J. Med. 2002; Vol. 346. - P. 1845-1853.
44. Bristow M.R., Saxon L.A., Boehmer J. et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 2004; Vol. 350. - Р. 2140-2150.
45. Carson P., Anand I., O’Connor C. et al. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial // J. Am. Coll. Cardiol. - 2005. - Vol. 46, № 12. - Р. 2329 -2334.
46. Cleland J.G.F., Daubert J.C., Erdmann E. et al. The CARE-HF study (Cardiac Resynchronisation in Heart Failure study): rationale, design and end-points. Eur. J. Heart Fail. 2001; Vol. 3. - Р. 481-489.
47. Cleland J.G.F., Daubert J.C., Erdmann E. et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med. 2005. - Vol. 352. -Р. 1539-1549.
48. Cleland J.G.F., Daubert J.C., Erdmann E. et al. Longterm effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur. Heart J. 2006. - Vol. 27. - Р. 1928-1932.
49. McAlister F.A., Ezekowitz J.A., Wiebe N. et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann. Intern. Med. 2004. - Vol. 141. - Р. 381-390.
50. Rivero-Ayerza M., Theuns D., Garcia-Garcia H.M. et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur. Heart J. 2006; 27: 2682-2688.
51. MERIT-HF Study Group. Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 2001-2007.
52. Bardy G.H., Lee K.L., Mark D.B. et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 2005; 352: 225-237.
53. Hunt S.A., Abraham W.T., Chin M.H. et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult - Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J. Am. Coll. Cardiol. 2005. Vol. 46: 116-1143.
54. Zipes D., Camm A.J., Borggrefe M. et al. ACC/AHA/ ESC 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death - Executive Summary. Eur. Heart J. 2006; 27: 2099-2140.
55. Swedberg K., Cleland J., Dargie H. et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology Eur. Heart J. 2005. Vol. 26: 1115-1140.
56. Рекомендации Всероссийского научного общества специалистов по клинической электрофизиологии, аритмологии и кардиостимуляции по проведению клинических электрофизиологических исследований, катетерной абляции и имплантации антиаритмических устройств. - Москва, 2005, 238 с.
57. Беленков Ю. Н., Васюк Ю. А., Галявич А. С. и соавт. Национальные Рекомендации ВНОК И ОССН по диагностике и лечению ХСН (второй пересмотр). Сердечная Недостаточность 2007; 8: в печати, www.OSSN.ru
58. Dilaveris P., Pantazis A., Giannopoulos G. et al. Upgrade to biventricular pacing in patients with pacing-induced heart failure: can resynchronization do the trick? Europace 2006; 8: 352-357.
59. Benditt D.G., Ermis C. Может ли быть обоснованным назначение двухжелудочкового кардиостимулятора без режима дефибрилляции у больных с сердечной недостаточностью? ISHNE Heart Failure World-Wide Internet Symposium; www.hf-symposium.org
60. Кузнецов В.А., Колунин Г.В., Харац В.Е. и соавт. Ресинхронизирующая сердечная терапия у больных с хронической сердечной недостаточностью без расширения комплекса QRS электрокардиограммы. Тер.Арх. 2005; 3: 77- 79.
61. Achilli A., Sassara M., Ficili S. et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and “narrow” QRS // J. Am. Coll. Cardiol. 2003; 42: 2117-2124.
62. Ghio S., Constantin C., Klersy C. et al. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. Eur. Heart J. 2004; 25: 571-578.
63. Perez de Isla L., Florit J., Garcia-Fernandez M.A. et al. Prevalence of echocardiographically detected ventricular asynchrony in patients with left ventricular systolic dysfunction J. Am. Soc. Echocardiogr. - 2005; 18: 850-859.
64. Bleeker G.B., Schalij M.J., Holman E.R. et al. Cardiac Resynchronization Therapy in patients with a narrow QRS complex. Eur. Heart J. 2006; 27; Abstract Suppl.: 193.
65. Avramidis D., Andrikopoulos G.K., Tzeis S. et al. Variability of QRS duration measurements in candidates for cardiac resynchronization therapy. Eur. Heart J. 2006; 27; Abstract Suppl.:.605.
66. Sogaard P., Egeblad H., Kim W.Y. et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy J. Am. Coll. Cardiol. 2002; 40: 723-730.
67. Kass D.A. Ventricular resynchronization: pathophysiology and identification of responders. Rev. Cardiovasc. Med. 2003; 4(Suppl 2): S3-S13.
68. Bax J.J., Ansalone G., Breithardt O.A. et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J. Am. Coll. Cardiol. 2004; 44: 1-9.
69. Bleeker G.B., Bax J.J., Schalij M.J., van der Wall E.E. Tissue Doppler imaging to assess left ventricular dyssynchrony and resynchronization therapy. Eur. J. Echocardiogr. 2005; 6: 382-384.
70. Gasparini M., Galimberti P., Agricola P., et al. Longterm follow-up after cardiac resynchronization therapy: Poor clinical outcome in patients enrolled in NYHA Class IV. Program and abstracts of the European Society of Cardiology Congress 2003; August 30-September 3, 2003; Vienna, Austria. Abstract 1962.
71. Butter C., Auricchio A., Stellbrink C., et al. Clinical efficacy of one year cardiac resynchronization therapy in heart failure patients stratified by QRS duration: Results of the PATH-CHF II trial. Program and abstracts of the European Society of Cardiology Congress 2003; August 30-September 3, 2003; Vienna, Austria. Abstract 1963.
72. Doshi R.N., Daoud E.G., Fellows C. et al. Left Ventricular-Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study). J. Cardiovasc. Electrophysiol. 2005: 16 (11); 1160-1165.
Рецензия
Для цитирования:
Ревишвили А.Ш., Неминущий Н.М. СЕРДЕЧНАЯ РЕСИНХРОНИЗИРУЮЩАЯ ТЕРАПИЯ В ЛЕЧЕНИИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ. Вестник аритмологии. 2007;(48):47-57.
For citation:
Revishvili A.Sh., Neminushchii N.M. CARDIAC RESYNCHRONIZING THERAPY IN TREATMENT OF CHRONIC HEART FAILURE. Journal of Arrhythmology. 2007;(48):47-57. (In Russ.)